knowledge -WSS

knowledge

author：Wikipedia 2025-09-28 14:50:03 - browse：687

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Surprise medical billing ban raises prices elsewhere

focus

WSS

Top private equity targets in 2023: cardiology, clinical trials, lasers

Hospitals are piloting generative AI tools as regulators play catch

340B reform proposal comes out of Senate working group

WATCH: Why do our ears pop?

Congress may force more Covid

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

focus

knowledge

hotspot

Walensky prepares to leave CDC — and Congress — behind

Researchers tackle phage therapy hurdles for wider adoption

Wildfire smoke exposes gaps in outdoor worker protections

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

MD Anderson's Padmanee Sharma responds to research credit suit

Medical records are filled with copy

Devoted Health’s losses in Medicare Advantage persist

Dobbs anniversary: the lost opportunity of abortion as health care

The CDC's new social media misinformation war

knowledge

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

340B reform proposal comes out of Senate working group

Problems with a popular proposal to regulate AI in health care

Why CTE doesn’t keep Americans from enjoying the Super Bowl

AI gets buy

The CDC's new social media misinformation war

focus

focus

entertainment

knowledge